Andon Health Hits Day High with 10% Surge, Outperforming Market

Andon Health Co., Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant surge in its stock price, gaining 10.0% on March 18, 2026. The stock reached an intraday high of CNY 59.95, reflecting a robust performance compared to the China Shanghai Composite, which only increased by 0.32% on the same day. Over the past week, Andon Health has shown a 2.44% increase, while its one-month performance stands at an impressive 45.4%. Year-to-date, the stock has risen by 49.73%, significantly outperforming the broader market index, which has only seen a 2.37% gain. Over the past year, Andon Health's stock has appreciated by 42.23%, further highlighting its strong market position. Despite these positive movements, the company has faced challenges, including a notable decline in operating profit and negative results over the last nine quarters. Financial metrics indicate a market capitalization of CNY 18,799 million, a P/E ratio of 25.00, and a dividend yield of 0.49%. These figures provide a comprehensive view of Andon Health's current standing in the market.